Second-Best Quarter, First Backlog Decline: Goldman Is Fairly Priced at $881, Not Cheap

Results vs. Consensus

Q3 2026 Scorecard

A 31% beat on a bank this size says as much about the estimate as about the bank. Consensus had absorbed 17 downward EPS revisions in the 30 days before the print, and it modeled equities near $5.0B, roughly a third below the second quarter's $7.42B. Goldman delivered $6.44B. Our own model, built in late September, had total revenue at $18,718M against the $18,679M reported, which is to say the quarter came in almost exactly where an unpessimistic forecast put it. The beat measures how far the Street had cut, not a step-change in the franchise.

Year-Over-Year Comparisons

Quarter-Over-Quarter Comparisons

Revenue

Revenue of $18.68B was the second highest in the firm's history and 8% below the record second quarter, and the composition of the decline tells you which parts of the July thesis held. The two volatility-linked intermediation lines fell together by $2.19B, from $7.53B to $5.34B. The two financing lines rose to $4.57B, a record, and now represent 46% of combined FICC and equities revenue against 37% in the second quarter. AWM rose $454M on incentive fees. Advisory rose 20%. In other words, the cyclical half contracted exactly as it should have, and the durable half held. Geographically, Asia produced $3.80B, up 90% year over year and now 20% of the firm, while EMEA fell 29% sequentially to $3.21B and was flat on the year.

Margins and Expenses

The third-quarter efficiency ratio of 60.5% (58.1% excluding the contribution) brings the year-to-date ratio to 59.4%, inside the 60% target and 270bps better than a year ago. Two lines moved in opposite directions. Compensation fell 16% sequentially to $5.12B because the firm lowered its full-year accrual. Non-compensation expense rose to $6.19B, up 30% year over year, with transaction-based expense of $3.02B (+54%) doing most of the work alongside the contribution. Transaction-based cost is the variable cost of equities activity, particularly in Asia, and the CFO said it will keep growing as long as that activity does. Pre-tax margin was 37.5%, down from 42.1% in the record second quarter.

EPS

Diluted EPS of $17.01 rose 39% year over year on 30% pre-tax growth, a bridge that runs through a smaller preferred dividend ($172M against $238M) and a 4% lower diluted share count (301.1M). The tax line went the other way. The quarterly rate of 24.4% lifted the year-to-date rate to 20.4% from 18.5% at mid-year as the first-quarter share-based award benefits faded. Those benefits total about $975M for nine months, worth about $3.20 of year-to-date EPS. With the full-year guide held at approximately 20%, the fourth quarter implies a rate in the high teens, a modest tailwind we include in our estimate. Nine-month EPS is $55.56, up 49%, on a 20.7% ROE.

Segment Performance

Geographic Mix

Asia was the only region to grow sequentially, rising 5% while the firm fell 8%, and it is now a fifth of Goldman's revenue against 13% a year ago. Nine-month Asia revenue of $10.46B is up 90%. The CFO tied most of the change in the regional mix to equities and equity financing activity. EMEA did the opposite, falling 29% sequentially to roughly where it stood a year ago.

Assessment: Asia is the cleanest evidence that the share gain we described in July was funded and structural: the region kept growing in a quarter when markets deleveraged and FICC softened. It is also now large enough that its concentration matters to the firm, and the client composition behind it remains undisclosed for a second quarter.

Investment Banking

Investment banking fees of $3,224M (+21% YoY, -5% QoQ) beat consensus by about $384M, and the mix inverted from the second quarter. Advisory set a quarterly record at $1,654M, up 20% sequentially as completed M&A volumes rose. Underwriting gave back: equity underwriting fell 32% to $666M after several September IPOs were withdrawn on valuation, and debt underwriting fell 12% to $904M from its record. Goldman remains first in announced and completed M&A and in equity and equity-related offerings for the year, with $1.5T of announced M&A and a lead of about $430B over its closest competitor.

The line that matters is the backlog. The release says it "decreased compared with the end of the second quarter of 2026 and decreased slightly compared with the end of 2025," and the presentation adds that the decrease was "primarily driven by a decrease in Advisory." On the call, management described the backlog as robust four times, twice as "very robust," without sizing it.

"Even amid very strong accruals in the quarter, our Investment Banking backlog remains very robust as strong revenue realizations in Advisory were largely offset by solid replenishment in equity underwriting." — Denis Coleman, Chief Financial Officer

Assessment: This is the July call working and then running out. We argued the record advisory backlog was a coiled spring, and it sprang: advisory rose 20% to a record. But a backlog that ends the quarter below where it started the year means the year's entire net build has been consumed. Advisory replenishment, not conversion, is now the question, and the call's "largely offset" language concedes that it did not keep pace.

Equities

Equities produced $6,441M (+72% YoY, -13% QoQ), the second best quarter in the firm's history. Intermediation fell to $3,076M from $4,157M but remains the second highest on record, driven by derivatives. Financing rose 3% to a record $3,365M on elevated average prime balances and Asia activity, and is up 96% year over year. Management reported no unusual items in the quarter.

"Demand for Equities financing continues to exceed available industry capacity, supporting attractive pricing and allowing us to remain selective in deploying resources. Following significant multiyear investment, our focus is increasingly on optimizing a diversified global portfolio, guided by our risk management framework, client relationships and returns." — Denis Coleman, Chief Financial Officer

Assessment: Read "increasingly on optimizing" against "the biggest delta, the largest sort of balance sheet extension is behind us" and the message is consistent: the financing build is moving from growth to yield management. That is a sound decision and it changes the model. Financing at ~$4.6B a quarter across FICC and equities is a durable floor we underwrite. It is no longer a line to compound at double digits sequentially.

FICC

FICC revenue of $3,471M was flat year over year and 24% lower sequentially, and it missed consensus by about $239M. Intermediation fell 33% sequentially to $2,264M on significantly lower mortgages and credit and lower rates, partly offset by significantly higher currencies and commodities. Financing held at $1,207M, its second highest level, on mortgages and structured lending. The CEO had warned at a September industry conference that FICC was "a little bit softer on a relative basis," so the shortfall was flagged, but its size still surprised.

Assessment: FICC is again the cyclical weak point. In July we retired the structural-impairment version of this bear point and kept the cyclical one, and the cyclical one has now returned in a quarter of sharp moves in rates. Intermediation of $2.26B is below the $2.44B of a year ago and a third below the second quarter's $3.38B. The financing half is steady, which is the same split as in equities: durable financing, cyclical intermediation.

Asset & Wealth Management

AWM revenue of $5,051M (+14% YoY, +10% QoQ) beat consensus by about $450M. Management and other fees set a record at $3,587M (+22%), about 35bps on average AUS. Incentive fees jumped to $587M from $112M, recognized after the IPO of a company in which ultra-high-net-worth clients had been given early access. Private banking and lending rose 20% sequentially to $827M on higher net interest from consumer deposits. Investments revenue fell to $50M on monetization timing and debt markdowns. AUS reached a record $4.10T on $97B of long-term net inflows, the 35th consecutive quarter of inflows, partly offset by $14B of liquidity outflows and $27B of net market depreciation, mostly in fixed income.

"For 2026, Wealth Management long-term net inflows are annualizing at 12%, well ahead of our 5% target, which underscores the strength of our client relationships built on trust and long-term performance." — David Solomon, Chairman and CEO

Alternatives AUS rose 26% year over year to $491B and produced $860M of management fees (+43%). Fundraising was $37B in the quarter and $122B for the year to date, and management raised its full-year expectation to roughly $150B from more than $125B; the year began with a $75B to $100B target. The firm also agreed to acquire NEOS, a derivative-income ETF manager with about $35B of AUS, and LCN Capital Partners, a triple-net-lease investment manager. Segment pre-tax margin was 26% in the quarter and 24% for the year to date, and segment ROE was 16.1%.

Assessment: This was the cleanest AWM quarter of the year. The inflow number carried no acquisition this time, the incentive-fee promise was met five times over, and the fundraising guide rose for the second consecutive quarter. Two cautions. First, $587M of incentive fees that management tied to one IPO is lumpy by construction. Second, the 30% margin target set at the fourth quarter of 2025 is still six points away after three quarters. AWM is becoming a better business; it is not yet the higher-multiple anchor the bull case needs.

Platform Solutions

Platform Solutions produced $170M, down 72% year over year and 23% below the second quarter's $221M, on further markdowns of the Apple Card portfolio held for sale. The segment lost $95M before tax. In July management guided quarterly revenue for the rest of the year to be broadly consistent with the second-quarter level.

Assessment: The first explicit forward marker on this segment missed by 23% in its first test. At under 1% of revenue it does not move the thesis, but a missed guide on a run-off book is a reminder that the Apple Card transition is not yet closed.

Key KPIs

*2Q26 long-term inflows included $31B from the Innovator acquisition, partly offset by $15B of outflows from the TFI disposition.

Key Topics & Management Commentary

Overall Management Tone: Confident on the franchise and noticeably more conditional on the environment than in July. Management said that conditions had moved from a "top decile" to a "top quartile" environment, conceded that the cycle flatters current returns, and framed both the AI financing cycle and the deal calendar as unknowable in the near term. Where it was less convincing was the backlog, which the release says fell and the call described as "very robust" without a number.

1. A Top-Quartile Quarter in a Worsening Macro

The quarter's operating backdrop changed sharply after the July call. The Fed raised rates in September for the first time in three years, the 10-year Treasury yield rose roughly 75bps from the start of July, renewed conflict in the Middle East disrupted energy flows, and inflation reaccelerated. The S&P 500 bank index fell 5.4% in the quarter while the broader market rose. Goldman produced its second-best revenue quarter against that backdrop.

"While the third quarter began with optimism around a potential resolution of the conflict in the Middle East, renewed geopolitical tensions and continued disruption of energy flows added complexity to the outlook, increasing oil prices, reigniting inflation concerns and driving bond yields higher." — David Solomon, Chairman and CEO

The CEO's characterization of the activity environment shifted with it. In July the posture was assured. This quarter he drew an explicit distinction between the "top, top decile" environment of May and June and the "top quartile" environment now, while noting that a 5% 10-year yield is not historically unusual.

Assessment: Producing $18.7B of revenue in a quarter that included a Fed hike is strong evidence of franchise resilience. The downgrade from top decile to top quartile matters more for the forward multiple than for the quarter. It is management's own statement that the second derivative of the environment has turned, and a stock rated on forward earnings has to take it seriously.

2. Advisory Converted; Now the Backlog Has to Refill

The July thesis rested on the backlog. The record advisory backlog at mid-year was the reason we expected advisory to accelerate, and it did, to a record $1,654M. The cost is visible in the forward indicator: the backlog fell over the quarter, led by advisory, and now sits slightly below where it began the year. Equity underwriting replenishment offset part of the decline, according to the CFO.

The new risks are timing risks. Several September IPOs were pulled after pricing came in 10% to 15% below May and June expectations, sponsor M&A remains below historical averages because portfolio marks exceed achievable exit values, and the midterm elections are a month away. Management argued that the current administration gives strategic M&A a 2.25-year window regardless of the election.

"This will come out, though, this activity will come. And I think the thing I'd look at, I look at the M&A levels and just recognizing the capital markets levels and just recognize it's been very light on sponsor activity. That sponsor activity is going to come. And when it comes, that will be a tailwind, but it has been slower than we would have expected at this point." — David Solomon, Chairman and CEO

Assessment: The advisory line delivered exactly what we said it would, and the backlog now tells us less than it did in July. A backlog that falls after a record conversion quarter is normal. A backlog that ends below its starting point for the year, in a hiking cycle with a softening IPO window, is the backlog's first quarterly decline in more than two years. We move the IB pillar to at risk until the fourth quarter shows replenishment.

3. Equities: The Rent Normalized and the Annuity Held

In July we split the equities franchise into two businesses: intermediation, which we called rent on a market regime, and financing, which we called an annuity. We modeled intermediation falling 28% to about $3.0B. It fell 26% to $3.08B. We modeled financing growing about 2.5%. It grew 3%. The franchise behaved as two businesses, and the split is now the cleanest way to value it.

"Importantly, we have created a higher revenue base with our more durable revenues having more than doubled since 2020 Investor Day and now representing approximately 45% of revenues for the year-to-date." — David Solomon, Chairman and CEO

The financing share of combined FICC and equities revenue rose to 46% in the quarter and 41% for the year to date, or $12.7B of financing revenue in nine months. Management again described industry financing capacity as short of demand, which supports pricing.

Assessment: This is the strongest support for a structurally higher Goldman multiple, and it held under pressure. The durable half of the markets business now produces about $18B a year. The open question is growth. With the financing build moving to optimization, durable revenue becomes a higher floor rather than a compounding engine, which supports a premium to history but not the July multiple.

4. FICC Is the Weak Link Again

FICC intermediation fell 33% sequentially and 7% year over year, with mortgages and credit significantly lower and rates lower, against strength in currencies and commodities. The miss against consensus was about $239M. JPMorgan, reporting the same morning, also missed on fixed income, so the weakness was industry-wide rather than specific to Goldman.

"Intermediation revenues declined 7% as lower results in mortgages, rates and credit were largely offset by strong performance in currencies and commodities. Financing revenues increased 14% to their second highest level, driven by strength in mortgages and structured financing." — Denis Coleman, Chief Financial Officer

Assessment: A quarter of sharp rate moves should help a rates franchise, and it did not. The likely explanation is client positioning: abrupt moves against a hiking cycle tend to reduce risk appetite rather than increase turnover in credit and mortgages. We return the FICC bear point to emerging. The structural concern stays retired; the cyclical concern is live, and the fourth quarter is seasonally weaker.

5. The Regulatory Agenda: Stress Tests Done, Basel and G-SIB Next, Liquidity After

The CFO welcomed the Fed's finalized changes to the CCAR stress test and said the firm is "hopeful" that Basel III endgame and the G-SIB surcharge proposals are finalized by year-end. He then flagged the next item on the agenda: liquidity regulation. Goldman holds $574B of average global core liquid assets, about 25% of total assets, and says its liquidity coverage ratio is the highest in its peer group.

"We expect regulatory focus to soon shift towards liquidity regulation reform. We currently have over $570 billion in average global core liquid assets, representing approximately 25% of our total assets, and our liquidity coverage ratio is the highest in our peer group." — Denis Coleman, Chief Financial Officer

Assessment: This is the real option that could reprice the SLR and CET1 constraints described in topic 10, and it is sitting on a year-end deadline. A quarter of total assets held in liquid assets is a deliberately conservative position, and any liquidity reform that frees part of it would release earning capacity. We assign no value to it in the base case, as in July, but the timeline is now specific enough to watch.

6. The $450M Contribution, and the Accrual That Offset It

Goldman made a "tax-efficient" charitable contribution of about $450M to Goldman Sachs Gives in the quarter, timed to the incentive-fee pull-through, and will make another "meaningful" contribution in the fourth quarter. Together they pull forward at least five years of planned giving.

"Additionally, given the strong pull-through of incentive fees this quarter, we made a tax-efficient charitable contribution of approximately $450 million as part of a planned acceleration of our philanthropic efforts. We also expect to make a meaningful contribution in the fourth quarter. Together, these actions will pull forward at least 5 years of planned charitable giving." — Denis Coleman, Chief Financial Officer

Assessment: Three things follow. The contribution is discretionary and was timed to a large, lumpy revenue item, so the add-back framing is fair as far as it goes. It is also not the only discretionary item in the quarter: the compensation accrual cut discussed in the Quality of Beat box was worth more. And the fourth-quarter contribution is unquantified, which makes the fourth quarter harder to model. The good news is that charitable expense largely disappears from 2027 through 2031, a small but real tailwind to the non-compensation ratio.

7. A 30% Compensation Ratio and the "Strategic Lens"

The year-to-date compensation ratio net of provisions was reduced to 30%, which the CFO called the firm's best estimate for the year. Asked whether the improvement reflects mix or a softer market for talent, he pointed to mix: balance-sheet-intensive financing businesses produce revenue with fewer people.

"And certain of the more durable activities, including the financing activities, we're using a lot of the firm's financial resources and risk appetite to drive that activity. And so there can be favorable compensation ratio benefits with respect to the growth of those activities. I would not say that we're seeing any diminution in terms of the market for talent, frankly, quite the opposite." — Denis Coleman, Chief Financial Officer

Assessment: The explanation is coherent, and it is a shift from July, when the CFO said there had been no structural change in the expense base. A firm whose fastest-growing revenue lines consume balance sheet rather than headcount should run a lower compensation ratio, and 30% is about a point below the first half. But the third quarter alone printed 27.4% because the full-year accrual moved, and that rate will not recur. Model 30%, not 27%.

8. AWM Delivers, Except on the Margin

Every forward marker management set for AWM in July was met or raised: incentive fees rose "materially," fundraising moved up to about $150B, wealth inflows are running at more than twice the target rate, and the segment made two acquisitions to fill product gaps in active ETFs and real estate. The incentive-fee outlook remains positive for the fourth quarter.

"Through our ultra-high net worth Wealth Management franchise, we provided clients early access to a high-growth investment opportunity and recognized incentive fees following the company's IPO. Based on our current outlook, we expect incentive fees to remain elevated in the fourth quarter." — Denis Coleman, Chief Financial Officer

Assessment: The volume side of AWM is ahead of plan, and that is real progress. The margin side is not. A 26% quarter on $587M of incentive fees and $3.6B of record management fees still leaves the year at 24%, six points short of target. When a quarter of record management fees and $587M of incentive fees cannot lift the year-to-date margin, the 30% target needs either more scale or a reset. We keep the pillar at risk, with a positive trend.

9. Rates, Inflation and the AI Financing Cycle

The CEO's AI commentary moved further toward caution. He repeated that demand for compute exceeds supply and that Goldman is central to the financing, then said that the quantum of financing required creates risk, that "not every project is going to be received as well," and that a reset is certain but its timing is not. He cited an estimate that the U.S. data center build-out could require more than $10T of investment through 2032.

"While we are proud of the privileged position we play in the AI investment cycle, no one knows how the demands for capital and compute will evolve as the broader AI ecosystem matures. That will only become clearer as technology and markets continue to develop. This uncertainty reinforces the importance of remaining vigilant around the types of activity we finance and how we manage risk as we support our clients." — David Solomon, Chairman and CEO

Assessment: In July management declined to underwrite the next six to 18 months. This quarter it added the mechanism by which the cycle could recalibrate: higher rates squeezing project returns. That mechanism is now in motion, with the 10-year near 5.3%. The firm is positioned as advisor, underwriter, distributor and investor, which spreads the opportunity, but it also spreads the exposure. Selective underwriting is the right posture, and it implies slower financing growth.

10. Capital: A 100bps Buffer and Buybacks Above Today's Price

CET1 fell 50bps to 12.4% as RWA rose on market and credit exposure, leaving a 100bps buffer above the 11.4% requirement. The firm repurchased $3.0B of stock (2.9M shares at an average $1,048.73) and paid $1.49B of dividends. The CEO said the buffer is at the top of its 50 to 100bps operating range and that earnings momentum generates capital.

"We talk about running with a 50 to 100 basis point buffer. We're at 100 basis point buffer. The firm has very good earnings momentum, so we generate capital. We feel comfortable with the fact that we have adequate capital to deploy in an active quarter in the fourth quarter." — David Solomon, Chairman and CEO

Assessment: The October 16 close of $881 is 16% below the third-quarter buyback average of $1,048.73 and 10% below the second-quarter average of $984.57. In July we said the second-quarter repurchases were 16% in the money. Both tranches are now underwater, a reminder that Goldman's buyback is a residual that buys most heavily when earnings are strongest, which is when the stock is most expensive. With a 100bps buffer and loans up 6% in the quarter, we model about $3.0B a quarter, not the $3.5B to $4.5B we carried in July.

11. Credit: Wholesale Impairments Arrive With Loan Growth

The provision of $368M was more than three times the second quarter's $102M. The CFO attributed it to two drivers: growth in the loan book, which rose 6% to $276B, and elevated impairments on a few wholesale names. Net charge-offs were $154M, an annualized 0.3%, and 85% of gross loans are secured.

"We've looked very carefully as we always do with the entire complexion of the portfolio. Our conclusion is they're highly idiosyncratic and noncorrelated set of names, but we had a couple of different names that we ended up taking incremental impairments against in the quarter. We don't think it's necessarily the signal of something else to come, but it was appropriate for those individual names." — Denis Coleman, Chief Financial Officer

Assessment: Idiosyncratic impairments are credible at this size, and an 0.3% charge-off rate on a mostly secured book is not a credit problem. But loan growth of 24% in a year, driven by a deliberate push to lend to more banking clients, followed by elevated wholesale impairments just as the Fed began hiking, is a sequence to watch. Provisions are likely to run nearer $300M to $400M a quarter than the $100M of the second quarter.

12. Succession: A Firm Denial, No Horizon

Press reports in September said the board could name the firm's President and COO as CEO as early as next year. Asked about it twice, the CEO denied that any process is underway and said he is "really enjoying the job." He did not give a horizon for his tenure.

"So I just want to be clear, there is no succession transition or time line underway at Goldman Sachs. The Board and I are singularly focused on our strategy to grow the firm and continue to serve our clients with excellence." — David Solomon, Chairman and CEO

Assessment: The denial is unambiguous about the present and silent about the future, which is normal for a sitting CEO. Both executives received large retention awards in 2025 that run through 2030, so leadership continuity is not a thesis risk. It is a source of headline noise, and the stock fell in the weeks the reports circulated.

Guidance & Outlook

Goldman does not guide revenue or EPS. Its forward markers are structural targets and a handful of specific items, and this quarter moved several of them.

The positive markers sit in AWM: fundraising, incentive fees and wealth inflows. The negative markers sit in investment banking and capital: the backlog, the CET1 buffer and the slower balance sheet build. The fourth quarter carries two items management did not size, the incentive-fee level and the charitable contribution, which roughly offset each other in our build.

Implied fourth-quarter setup: Nine-month EPS is $55.56. Our fourth-quarter build uses revenue of about $17.0B to $18.7B: investment banking near $2.9B to $3.2B as the backlog works down, FICC at $3.2B to $3.5B in a seasonally weaker quarter, equities at $5.6B to $6.2B, and AWM at $4.9B to $5.3B with elevated incentive fees. Compensation accrues at 30% net of provisions for the year, non-compensation expense includes a contribution of about $400M, and the tax rate is about 18.5%, as the ~20% full-year guide implies. That produces fourth-quarter EPS of roughly $15 to $18.

Street at: Before the print, full-year consensus stood near $67.50, with a fourth-quarter estimate near $14.90. Adding the third-quarter beat lifts the full-year figure into the low $70s, close to our revised midpoint.

Guidance style: More specific on AWM and expenses than any recent call, and less specific on the investment banking pipeline. Management sized the AWM markers that improved and left unsized the investment banking marker that weakened.

Analyst Q&A Highlights

How the Rate Rout Changed the Activity Environment

The first question on rates asked directly whether the global bond selloff had cooled client activity and how higher long-end yields entered client discussions. The answer was the most revealing characterization of the call: a candid statement that the environment had stepped down a level, combined with an argument that the new level is still strong.

Q: "There has been a lot of fears in the investor community that the bond market rout globally was going to have a chilling effect on activity levels. And given sort of how you framed the pipeline, maybe talk about how discussions have evolved or take into account higher long-end rates and if that's a factor?"
— Erika Najarian, UBS

A: "So I know people looked at the quarter and felt that it felt a little different than it did in the second quarter. And I think that's fair. I would say that if I go back to the end of May or June, I would call it like a top, top decile environment for, kind of, market activity and capital markets activity. But now in a top quartile environment, and that's still really, really good when you think about long periods of time."
— David Solomon, Chairman and CEO

Assessment: The step from top decile to top quartile is management's own measure of the second derivative, and it is what a forward multiple should price. It also supports the bull argument that a fourth-quartile environment is a long way off. Both readings can be true, and together they describe a peak that has passed rather than a cycle that has ended.

Whether the Investment Banking Cycle Has Peaked

The question about the cycle cited higher rates, withdrawn IPOs, the coming midterms and a smaller backlog. The answer declined to call a peak, repeated that the backlog is robust, and attributed the IPO withdrawals to valuation gaps set months earlier rather than to a closed market.

Q: "I'd love to get some color on where you think we are in the cycle. The macro seems to be marginally more challenging, higher rates. We've seen a bunch of IPOs get pulled. We probably get a change in the political climate post-U.S. midterm elections. Your backlog seemed impressive, but they did pull back a little bit. So just give me a sense of where you think we are in the cycle, have we peaked or is there more to go?"
— Christian Bolu, Autonomous Research

A: "I know everybody wants to call the peak. It's hard to call the peak, but let's just step back. ... Our backlog is incredibly robust. It's fair to say that we had enormous accruals in the quarter, but if you listen to our prepared remarks, we were very forward about how robust the backlog remains. ... IPOs that came in September were really the result of conversations in May and June around valuation expectations, things got a little bit softer in September."
— David Solomon, Chairman and CEO

Assessment: The explanation for the IPO withdrawals is plausible, and it is also a description of a market repricing. When buyers will pay 10% to 15% less than sellers expected three months earlier, issuance slows until expectations adjust. "Incredibly robust" is an adjective, not a figure, and the release itself says the backlog fell.

Whether Financing Becomes the Choke Point for AI Capex

A question citing a semiconductor CEO's public doubts about AI capex financing asked whether financing will be the binding constraint on the build-out. The answer opened with an admission of uncertainty and then described the specific mechanism by which the cycle could reset.

Q: "Do you share that concern that the real choke point for AI CapEx will be financing, especially given rates moving higher, it's unclear what the returns look like. Frame that for us, given you probably have one of the best visibilities on what the appetite looks like."
— Ebrahim Poonawala, Bank of America

A: "I'm probably going to disappoint you on my answer, which is I don't know and nobody knows. ... It may be, over time, as the financing needs grow, that there's pressure on rates and that will affect the returns and the viability of certain projects. ... There will be a point in time when this recalibrates, resets, for sure. And when that does happen, of course, there will be some bumps."
— David Solomon, Chairman and CEO

Assessment: "I don't know and nobody knows" is honest, and, as in July, management declined to underwrite the AI cycle's near-term path. What is new is the explicit link between rising rates and project viability, delivered in a quarter when the 10-year reached a two-decade high. The firm is telling investors which variable to watch.

Whether Prime Brokerage Adds Durability or Cyclicality

A follow-up challenged the durability argument directly: if equity markets fall and hedge funds deleverage, prime balances fall with them, so is financing durable revenue or leveraged market beta? The answer accepted the cyclicality, argued for durability over three to five years, and included the most quotable sentence of the call.

Q: "When we look at the growth in prime and equity financing, you could make the argument that it's adding to the cyclicality of the business, if there's like deleveraging among hedge funds, et cetera. ... How should we think about equity financing actually making these earnings more durable versus adding to the cyclicality?"
— Ebrahim Poonawala, Bank of America

A: "Equity markets go up. Equity markets come down. Okay, when equity markets come down, okay, there's a deleveraging, okay? ... look, we've grown our revenues over the last 5 years since 2022 by 11% compounded on the top line. I do not believe we're going to grow our revenues by 11% compounded on the top line for the next 5 years. There will be steps and starts as equity markets move around."
— David Solomon, Chairman and CEO

Assessment: The CEO volunteered that the next five years will grow more slowly than the last five, and that financing is cyclical within a durable trend. That is the right framework, and it argues for valuing financing at a premium to intermediation but at a discount to a true annuity. It is also a statement that the recent revenue growth rate should not be capitalized.

Degrossing and the Source of Financing Growth

A question asked whether the quarter's hedge-fund degrossing showed up in financing, and how much of the growth came from balances versus pricing. The answer gave the sequential growth rate, attributed the slowdown to market deleveraging, and described client selection as the valve the firm can use when balances fall.

Q: "The third quarter was perceived as a bit of a degrossing period. So curious whether or not you saw that? And is it possible to break down some of the growth that you've seen in those trading revenues between how much is tied to average balances growing versus the pricing benefits that you highlighted?"
— Brennan Hawken, BMO

A: "The growth rate for financing, in particular, on a sequential basis was about 3%. So I think there was deleveraging in the quarter. I think there was some disruption over the course of the quarter. And so the trajectory did not sustain substantial growth. It's still very healthy."
— Denis Coleman, Chief Financial Officer

Assessment: The balance-versus-pricing split was not given, which leaves the pricing-power claim untested. A record line growing 3% in a degrossing quarter is resilience, not growth, and it follows three consecutive quarters of sequential growth above 20%. Combined with the SLR answer below, it marks the end of the compounding phase.

Where the Leverage Ratio Settles

The July call left the leverage ratio's floor unnamed. This quarter's question asked again where the firm is comfortable running SLR while financing grows. The answer did not give a number but did give a direction, and that direction answers the question we flagged in July.

Q: "Given financing activity is much more leverage intensive, you guys have obviously seen outsized gains on the financing side. Speak to where you're comfortable running under the SLR constraint, while supporting continued balance sheet expansion."
— Steven Chubak, Wolfe Research

A: "I think it's fair to say that the biggest delta, the largest sort of balance sheet extension is behind us. We're now migrating to a zone where we run a buffer in SLR, much like we run in CET1 ratio. So we feel like we have the requisite capital we need to support the growth in client activity as we head into the fourth quarter, but I wouldn't expect a significant movement from here."
— Denis Coleman, Chief Financial Officer

Assessment: This is the answer to the question we raised in July, and it confirms the bear point in its mild form. The leverage ratio stops falling because the balance sheet stops extending at the same pace. The cost is growth in the financing engine, not a capital problem. "Run a buffer in SLR, much like we run in CET1" is the language of a binding constraint being managed.

Buybacks at Three Times Tangible Book

The sharpest capital question of the call noted that the firm was buying back stock at about 3x tangible book while its leverage ratio is the lowest among peers, and asked about priorities for 2027. The answer restated the order of claims on capital.

Q: "I am a little bit surprised that you are still buying back a ton of stock at 3x tangible, especially as your SLR is lower than peers. So maybe just talk through how we should think about capital management priorities as you move into 2027."
— Christian Bolu, Autonomous Research

A: "We will deploy into the franchise as a matter of priority. We do expect to continue to invest in the sustainable growth of our dividend. It's obviously up 25% year-over-year. It's now at $5 a share. It was $4 a year ago. 5 years ago, it was $2 a share. ... And obviously, with excess, we'll return it to shareholders and make sure we have the right buffer to operate the firm."
— Denis Coleman, Chief Financial Officer

Assessment: The question was right on valuation: the third-quarter average of $1,048.73 was about 3.1x tangible book of $341.43, and the stock now trades at 2.6x. The answer was right on priorities. Clients first, dividend second, buyback as residual is consistent with what the CEO said in July. The implication for holders is that buybacks will not set the price floor.

How Much of the ROE Is the Cycle

The final substantive question asked how much of the firm's outperformance against its ROE targets is cyclical versus structural. The answer claimed a structural uplift and, unusually, agreed that the current environment flatters returns.

Q: "Your outperformance on your ROE targets, maybe a comment or 2 on your views on how much is cyclical versus structural?"
— Christopher McGratty, KBW

A: "I'm not going to speculate on -- through the cycle as to how the returns balance out. ... I will say at the moment, and I've said it on the call 3 times, we're in a very good environment. We're in a top quartile environment. And so does that flatter the -- what will be the average returns through the cycle? Absolutely. But structurally, the base returns of the firm have been meaningfully uplifted over the last 5 years."
— David Solomon, Chairman and CEO

Assessment: "Absolutely" is the most useful word on the call for valuation. Management will not put a number on through-cycle returns, and its stated target remains mid-teens. At 2.36x book the stock prices roughly 19% sustainable ROE at a 10.5% cost of equity. That is above the target, below this year's 20.7%, and in line with an environment the CEO says flatters returns.

What They're NOT Saying

1. How much the backlog fell: The release says the backlog "decreased" from the second quarter and "decreased slightly" from the end of 2025, and the presentation attributes the decline mainly to advisory. Neither document nor the call sizes it. Management described it as robust four times on the call, including "very robust" and "incredibly robust." The forward indicator that carried the July thesis has turned, and the one number that measures it is not disclosed.
2. How concentrated the incentive fees are: Management tied the $587M to fund distributions and to the IPO of a company in which wealth clients had early access. It did not name the company, give that IPO's share of the $587M, or quantify "remain elevated" for the fourth quarter. Incentive fees were about 12% of AWM revenue in the quarter.
3. The size of the fourth-quarter contribution: The CFO said "meaningful" and gave the total pull-forward as "at least 5 years" of planned giving, but no dollar figure. It is a direct input to fourth-quarter EPS.
4. Which wholesale names drove the impairments: Management said "a couple of different names," described them as idiosyncratic and uncorrelated, and gave no sector. We have no evidence of a link to any theme, but in a quarter spent discussing data center financing risk and higher rates, the sector would have been useful.
5. Who the Asia clients are: Asia is now 20% of firm revenue, up from 13% a year ago, and the CFO again pointed to the geographic table as evidence of the strategy. The risk framework includes "concentration management," but for a second quarter there is no client or product concentration data behind the fastest-growing region.
6. How long the CEO intends to stay: Asked twice, the CEO denied that a succession process or timeline is underway. He did not say how long he intends to remain CEO, which was the substance of the second question.

Market Reaction

• Pre-print setup: Closed at $893.95 on October 12. Up 1.7% year to date against the S&P 500's 14.0%, up 13.6% over the trailing twelve months, and down 13.1% over the trailing 30 days. The 52-week closing range was $744.60 to $1,152.07, so the stock entered the print 22.4% below its July closing high. Options implied a move of about 4.6% either way.
• Reaction session (October 13, results before the open): Opened at $923.00, a 3.2% gap, and traded between $891.01 and $931.00. Closed at $891.91, down 0.2% (-$2.04), about $1 above the session low.
• Volume: 4.9 million shares against a 2.0 million 30-day average, or 2.4x normal.
• Benchmark and peers: The S&P 500 was flat on the session. Of the four banks reporting that morning, Goldman finished best: JPMorgan fell 0.9%, Wells Fargo 3.1% and Citigroup 5.6%.
• Following sessions: Fell 1.5% to $878.72 on October 14 as hotter-than-expected September core CPI pushed the 10-year yield to about 5.28% and the S&P 500 fell 1.1%. Rose 1.4% to $891.28 on October 15 and fell 1.1% to $881.26 on October 16. From the pre-print close through October 16 the stock fell 1.4%, against 1.9% for the S&P 500.

A beat the tape would not hold. The open priced the beat: a 3.2% gap on a 31% EPS surprise, close to the options-implied move. The rest of the session gave it back. The call started at the open, and the content that drove the fade was in it: the backlog decline, the shift from top decile to top quartile, the FICC shortfall, and a CEO who said "nobody knows" about the AI financing cycle. A close $1 above the session low on 2.4x volume is distribution, not indifference.

Relative resilience in a rate-driven selloff. The more informative frame is relative. Goldman fell 0.2% on a morning when the other three reporting banks fell between 0.9% and 5.6%, and over the four sessions through October 16 it held up slightly better than the index through a hot inflation print. The market did not punish the quarter. It declined to rerate the stock while the rate tape set the direction for the whole group. The stock had already fallen 22% from its July high on rates, the CEO's own September warning that FICC was softer, succession headlines and 17 downward estimate revisions. The print stopped the slide without reversing it.

Our reading is that the market now values Goldman on the forward environment rather than the trailing quarter, which is the right approach and the reverse of July. In July a 9% rally capitalized the best quarter in the firm's history as a new baseline. In October a 31% beat moved the stock by -0.2%, because the indicators that drive next year's earnings (the backlog, the rate path, the financing growth rate) all weakened. The market is now discounting much of what concerned us in July.

Street Perspective

Debate: Is a 23% Drawdown an Entry Point, or the Start of a Rate-Cycle Derating?

Bull view: The constructive camp argues that the stock has fallen 23% while earnings estimates have barely moved, leaving a franchise that just produced its second-best quarter at about 12x forward earnings. Durable revenue is now about 45% of the total, financing is more than 40% of markets revenue, and the price targets set after the print sit mostly at or above $1,000.

Bear view: Skeptics point to the regime. The Fed is hiking, the 10-year is at a two-decade high, inflation is reaccelerating, and investment bank multiples have historically compressed in hiking cycles because both the cost of equity and the activity outlook move against them. On this view 2.4x book is still a premium multiple, and it rests on returns the CEO himself says the environment flatters.

Our take: Both camps have a point, and the arithmetic places the stock close to fair. At a 10% cost of equity and 4% growth, 2.36x book capitalizes an 18.2% sustainable ROE. At 10.5%, which better reflects a 5.3% 10-year, it capitalizes 19.4%. Management's own through-cycle target is mid-teens, and this year is running at 20.7% in what it calls a top-quartile environment. The stock is no longer pricing the peak, as it was in July, but it is pricing a level above the stated through-cycle target. That supports a Hold, not an Outperform.

Debate: Has the Investment Banking Cycle Peaked?

Bull view: The optimistic case is that advisory just set a record, M&A league-table leadership is the widest it has been, sponsor activity is still to come, and the backlog decline is the mechanical result of record conversion. A top-quartile environment with an administration seen as friendly to deals has room to run, and the AI build-out supports issuance.

Bear view: The skeptical case is that the backlog ended below its starting level for the year, IPOs were withdrawn in September on valuation, sponsors are holding assets at marks they cannot achieve, and higher rates are the classic constraint on leveraged M&A. Peaks in investment banking are visible only afterward, and the first decline in the leading indicator is how they usually begin.

Our take: The bear camp has the better leading indicator and the bull camp has the better current data. We treat this quarter as the likely high-water mark for advisory in the near term, and we model fourth-quarter investment banking fees 5% to 10% below the third quarter. If the fourth-quarter backlog rebuilds, that call is wrong, and the bull case on the pillar is restored.

Debate: Is Financing Durable Revenue or Leveraged Beta?

Bull view: The bull argument is that financing is structurally durable. It is priced on spread, demand exceeds industry capacity, it grew through a degrossing quarter to a record, and the tradable asset base it finances grows with GDP and market capitalization over time. A business that is 46% of markets revenue and still growing deserves a higher multiple than trading.

Bear view: The bear argument is that financing is the same market beta in a different form. Prime balances fall when equity markets fall, the leverage ratio has capped the build, and management has just said the largest extension is behind it. A line that grew 3% sequentially in a mild degrossing could fall in a real one.

Our take: Financing is durable relative to intermediation and cyclical relative to a fee annuity, and the CEO said as much. We underwrite about $4.6B a quarter across FICC and equities as a floor that falls perhaps 15% to 20% in a market drawdown rather than 40% or more like intermediation. That supports a premium to Goldman's historical multiple. It does not support the July multiple, because the growth phase has ended.

Debate: Can AWM Become the Multiple's Anchor?

Bull view: The constructive view notes record management fees up 22%, wealth inflows at more than twice the target rate, alternatives fundraising at about $150B with the target raised twice this year, and acquisitions filling product gaps. On this view AWM is compounding into a durable, fee-based earnings stream that should eventually be valued like an asset manager.

Bear view: Skeptics point to a 24% year-to-date pre-tax margin against a 30% target, a segment ROE of 16% against the firm's 19%, and a third-quarter beat driven largely by IPO-related incentive fees. Asset managers are valued on margins and organic growth, and the margin has not moved.

Our take: The volume story is ahead of plan and the margin story is behind it, and the multiple follows the margin. If the year ends near 24%, the 30% target needs a reset or a credible path. Until then, AWM supports the earnings floor but does not justify a higher multiple.

Model Update Needed

Third Quarter: Our Model Against the Print

The model's total revenue was within $39M of the print, but the components were not: it was too high on FICC and investments and too low on advisory and incentive fees. The equities normalization, the most important single call in the July thesis, landed within 3%.

Forward Revisions

Valuation impact: Our fair value falls 23% while our FY2027 estimate falls 4%. Most of the change is the discount rate, not the business. We build fair value from two legs. On earnings, 12x to 13x our $74 FY2027 estimate gives $888 to $962; that multiple is a premium to Goldman's long-run history, justified by the durable revenue mix, and a discount to the July multiple, justified by a hiking cycle and the end of the financing growth phase. On book, forward book value of about $392 at a justified 2.15x to 2.46x, which corresponds to 18% to 20% sustainable ROE at a 10.5% cost of equity and 4% growth, gives $844 to $965. Together they support $875 to $975, with a midpoint of $925, about 5% above the $881 close. With the 2.3% dividend yield, the expected twelve-month total return is about 7%, roughly what we expect from the S&P 500. Under our framework, that is a Hold.

The sensitivity is to the sustainable ROE assumption. Each point of sustainable ROE is worth about 0.15x book, or roughly $60 a share. If Goldman can sustain 21% through the cycle, which is above this year's result, fair value moves above $1,000 and the stock is an Outperform. At the mid-teens through-cycle target, justified book value is closer to 1.7x, or about $660. The current price sits between those cases, closer to the optimistic one.

Thesis Scorecard Post-Earnings

Scored against the standing thesis carried since our Q2 2026 note, pillar for pillar, with one new risk.

Overall: The thesis weakened at the margin, and the valuation case improved by more. On the franchise, the quarter confirmed what we argued in July: equities split into a cyclical half and a durable half exactly as modeled, advisory converted the backlog into a record, and AWM met every promise except the margin. On the outlook, it moved against Goldman. The backlog turned, FICC weakened, the financing engine reached a plateau, capital became tighter, and the rate regime changed. Four tags moved toward the bears and one, valuation, moved decisively in the other direction. That combination produces a stock that is fairly priced rather than expensive, and it does not yet produce one that is cheap.

Action: Hold. The July call has worked; the upgrade needs a lower price or a better tape. In July we said we would revisit Outperform on a pullback toward the high $900s. We have revisited it. The price fell further than that, to $881, but over the same period the 10-year rose about 75bps, the Fed began hiking, and the backlog began to fall. The margin of safety that a lower price would have provided in a stable rate environment has been largely offset by a higher cost of equity and a weaker forward indicator. We would upgrade to Outperform below about $800, where the stock would price about 18% sustainable ROE on current book at a 10.5% cost of equity, the low end of our range, or on a fourth-quarter backlog rebuild with the 10-year stabilizing. We would move to Underperform if FY2027 earnings power falls below about $65 (sustainable ROE near 17%) while the stock holds above 2.3x book. Holders have no reason to sell a franchise this well positioned at 12x earnings. New buyers can wait for the rate cycle to show its hand.